The role of human CD4+ T cell subsets in cancer immunotherapy is still unclear. Here, the authors show that CD26 identifies three CD4+ T cell subsets with distinct immunological properties in both healthy individuals and cancer patients.
- Stefanie R. Bailey
- Michelle H. Nelson
- Chrystal M. Paulos